Resistance exercise to improve thinking during perimenopause
Official title: Resistance Training and Cognitive Health in Perimenopause
Run by University of British Columbia · NCT07272174 · Data updated 2026-11-12
This program will test whether twice-weekly progressive resistance training for six months helps memory and thinking in physically inactive perimenopausal biological females aged 40–55 who have noticed cognitive changes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 55 Years |
| Sex | Women only |
| Enrollment | 50 (estimated) |
| Sponsor | University of British Columbia Academic / other |
| Locations | 1 site (Vancouver, British Columbia) |
| Status | Recruiting |
| Started | March 30, 2026 |
| Main results expected | December 15, 2026 |
| Study ends | January 30, 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07272174 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are physically inactive biological females aged 40–55 who are perimenopausal, report subjective cognitive complaints, have a MoCA score >26, and can safely perform moderate-intensity resistance exercise.
✕Probably not a fit
People already doing regular progressive resistance training, those with diagnosed cognitive impairment or dementia, or individuals who cannot safely exercise due to cardiac or other medical risks are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a 26-week, assessor-blinded, randomized proof-of-concept trial enrolling 50 physically inactive perimenopausal biological females aged 40–55 with subjective cognitive complaints. Participants are randomized to twice-weekly progressive resistance training (lifting free weights or using weight machines) or to balance, flexibility, and tone (BAT) exercises, with interventions delivered over 26 weeks. The primary outcome is change in verbal episodic memory measured by the Rey Auditory Verbal Learning Test (20-minute delay), with additional cognitive and brain-health measures collected. The trial tests whether targeted resistance training during the menopause transition can counter the memory and brain changes many females report at midlife.
Why it matters
Potential benefit: If successful, the program could improve verbal memory during perimenopause and provide a low-cost approach to support midlife brain health.
How similar studies have gone: While exercise has improved cognition in older adults, randomized trials of progressive resistance training specifically in perimenopausal females are novel and have not been previously reported.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Are biological females, as assigned at birth * Are aged between 40 and 55 years * Had at least 1 menstrual period in the last 10 months * Are perimenopausal based on STRAW +10 Staging System, or answer "yes" to MQ6 questions of changes in periods, having hot flashes, or vaginal dryness, pain, or sexual concerns * Have an intact uterus * Have a Montreal Cognitive Assessment (MoCA) score \>=26/30 for in-person or \>=19/22 for telephone , indicating normal cognition * Have subjective cognitive complaints defined as responding "yes" to "Do you feel like your memory or thinking is becoming worse?" * Completed high school education * Read and speak English with acceptable visual and auditory acuity * Are able to safely engage in moderate-intensity PRT as indicated by the PAR-Q+; and * Are able to provide informed consent. Exclusion Criteria: * Are engaged in regular PRT (i.e., 2x/week) in the prior three months * Are diagnosed with cognitive impairment or dementia of any type * Are at high risk for cardiac complications during exercise * Have clinically important peripheral neuropathy or severe musculoskeletal or joint disease that impairs mobility * Are taking medications that negatively affect cognitive function, such as anticholinergics, major tranquilizers, and anticonvulsants * Have a BMI \<15 or anorexia nervosa; g) had surgical menopause * Had endometrial ablation that resulted in the loss of menstruation * Have polycystic ovarian syndrome * Currently undergoing chemo * Are using estrogen-containing contraception in the last 12 months * Had premature ovarian failure; or * Are already enrolled in a drug or exercise trial
Where it's running
-
University of British Columbia
Vancouver, British Columbia, Canada Recruiting
Study contacts
- Principal investigator: Teresa Liu-Ambrose, PhD — University of British Columbia
- Study coordinator: Teresa Liu-Ambrose, PhD
- Email: teresa.ambrose@ubc.ca
- Phone: 6046178047
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding immune clues to depression in perimenopause
This study tests whether immune and epigenetic changes during perimenopause help explain why some women develop depression.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Plant extract supplement for menopausal symptoms in women around menopause
A plant-extract dietary supplement is being tested to see if it helps hot flashes and related symptoms in women aged 42–60 who are nearing or just past menopause, compared with a placebo.
-
Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety
Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.
-
CARAMEL: Personalizing Heart Risk in Women 40–60
This observational study tests a personalized cardiovascular risk-stratification approach for women aged 40–60 using multi-source data and a digital self-management tool.
-
Samphire Guided Care for Wellbeing at Work
This study tests a 12-week digital program with at-home neuromodulation to see if it helps women with menstrual or perimenopausal symptoms feel better at work and in daily life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.